The global Compression Therapy Market is anticipated to augment at a robust CAGR of 5.4% across the valuation period from 2022 to 2030. The global market reached a revenue of US$ 3.01 Billion in 2022 and is predicted to surpass a revenue of US$ 4.59 Billion by 2030. According to the historical analysis conducted by …
Category Archives: Healthcare Trends
Stethoscope Market is expected to reach a valuation of US$ 914.1 Million by 2030 | FMI
The global Stethoscope Market is expected to reach a market valuation of US$ 582.5 million in 2022, growing at a healthy CAGR of 5.8% between 2022 and 2030. Stethoscope sales are expected to increase, with the market reaching US$ 914.1 million by 2030. Stethoscopes are one of the most important tools used by medical professionals …
Skincare Market is projected to reach a valuation of US$ 230.21 Billion by 2032 | FMI Study
The global Skincare Market is expected to grow significantly at an 8.1% CAGR between 2022 and 2032. By 2022, the market is expected to grow to a global market worth US$ 131 billion. The global skincare industry is expected to reach US$ 230.21 billion by 2032, owing to rising demand and growth. Personalized things are …
Over-The-Counter (OTC) Veterinary Drugs Market size is estimated to cross US$ 18.14 Billion by 2032
Over-The-Counter (OTC) Veterinary Drug sales are expected to grow at an 8.1% CAGR from 2022 to 2032, reaching US$ 18.14 billion by the end of 2032. In 2021, online pharmacies held more than 38% of the total market share. There are variety of drugs available in the market as Over-The-Counter (OTC) veterinary drugs for the …
Transcatheter Mitral Valve Market is expected to reach US$ 3.3 Billion by 2032 at a CAGR of 13.5 %
As per the latest industry analysis by Future Market Insights, valuation of the global Transcatheter Mitral Valve Market was around US$ 831.1 Mn in 2021 and is projected to exhibit a CAGR of 13.5% over the forecast period. The market is expected to reach US$ 3.3 Bn in 2032. Doctor-investigators are focusing on percutaneous replacement of a damaged mitral valve in light of …
Downstream Processing Market | Merck Millipore, Danaher Corporation, 3M Company, Boehringer Ingelheim | By 2032
The market for Downstream Processing Market is anticipated to grow at a CAGR of 11.3% between 2022 and 2032, reaching a market valuation of US$ 72.3 Bn by the end of 2032. The global downstream processing market size was valued at US$ 22.0 Bn in 2021 and is anticipated to enjoy a valuation of US$ 24.9 Bn …
Competent Cells Market is expected to reach US$ 5.9 Bn by 2032, with sales revenue expected to register an 11.1% CAGR
By the end of 2022, the Competent Cells Market is anticipated to reach US$ 2.1 billion, growing at a double-digit rate of 11.1% CAGR (2022-2032). By 2032, the market’s sales are projected to be worth $5.9 billion USD. Chemically competent cells held the market’s top spot in terms of product type in 2021, with a …
Monoclonal Antibodies Market is expected to reach US$ 647.01 Billion by 2032 at a CAGR of 12 %
The global Monoclonal Antibodies Market is projected to increase at a CAGR of 12% during the forecast period between 2022 and 2032, reaching a total of US$ 647.01 Billion by 2032, according to a report from Future Market Insights (FMI). From 2017 to 2021, sales witnessed significant growth, registering a CAGR of 6.1%. Human mAbs …
Soft Tissue Repair Market | Wright Medical Group N.V., Integra LifeScience Corporation, Medtronic Plc, CONMED Corporation | By 2032
The global Soft Tissue Repair Market is anticipated to reach US$ 6.61 billion in 2022 and grow at a CAGR of 5.8% from 2022 to 2032. By 2032, market sales are anticipated to be worth US$ 11.66 billion. Based on region, North America held a 34.2% demand share of the global soft tissue repair market …
Biopharmaceutical Contract Manufacturing Market | Catalent Inc., Lonza Group Ag, Patheon N.V., Abzena Plc. | By 2029
Global Biopharmaceutical Contract Manufacturing Market was estimated to be worth roughly US$ 8.4 billion in 2021 and is expected to grow at a CAGR of 10.5% to reach US$ 18.7 billion by 2029. A few benefits provided by biopharmaceutical manufacturing businesses include access to pricey technologies, a shorter overall time to market investment for new pharmaceuticals, and increased flexibility. Several multinational corporations …